Cat.#: ACPP-1636
| Despition | Vasopressin |
| SIZE | 5 mg |
| Sequence | C[Cys-Tyr-Phe-Gln-Asn-Cys]-Pro-Arg-Gly-NH2. |
| Purity | > 98.0% (SDS-PAGE) |
| Form | Sterile Filtered White lyophilized (freeze-dried) powder. |
| Storage | Lyophilized was stored and desiccated below -18°C. |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1026 | Recombinant Human Neuropilin 1 Protein (6×His Tag) (AC1026) | 50 µg | inquiry |
| ACPP-1841 | Human DDAH1 Protein (AC1841) | 5 µg | inquiry |
| ACPP-1562 | Human TAGLN3 Protein (AC1562) | 5 µg | inquiry |
| ACPP-1754 | Human VEGFC Protein, Sf9 (AC1754) | 2 µg | inquiry |
| ACPP-1764 | Human ANTXR2 Protein (AC1764) | 2 µg | inquiry |
| ACPP-1820 | Rat CNTF Protein, His (AC1820) | 2 µg | inquiry |
| ACPP-1482 | Human FGFR1 Protein (AC1482) | 2 µg | inquiry |
| ACPP-1579 | Human Leptin Protein, His (AC1579) | 5 µg | inquiry |
| ACPP-1358 | CRMP3 Blocking Peptide (AC1358) | 250 µg | inquiry |
| ACPP-1372 | Exendin 4 (AC1372) | 20 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.